SM
LXRX icon

Sabby Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Sabby Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-457
Closed -$752K – 192
2017
Q2 		$752K Buy
457
+82
+22% +$1.27K 0.05% 114
2017
Q1 		$538K Buy
375
+254
+210% +$3.77K 0.03% 175
2016
Q4 		$167K Sell
121
-479
-80% -$7.68K 0.01% 250
2016
Q3 		$1.08M Sell
600
-379
-39% -$6.1K 0.04% 175
2016
Q2 		$1.41M Buy
+979
New +$13.3K 0.07% 134
2015
Q4 		– Sell
-260
Closed -$279K – 348
2015
Q3 		$279K Buy
+260
New +$2.84K 0.01% 328

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return